Clinical characteristics and risk factors for <i>Clostridioides difficile</i> infection in the hematopoietic cell transplantation population
CDI is a common, early complication of HCT particularly among allogeneic recipients. Penicillin exposure, prior chemotherapy, and cord blood stem cell source are key risk factors, while macrolide use is associated with recurrence. Our findings highlight potential targets for risk-stratified prevention strategies.
Authors
- Abhishek Deshpande (ORCID: https://orcid.org/0000-0001-5522-2995)
- Joseph O’Brien (ORCID: https://orcid.org/0009-0006-9905-7139)
- Matthew A. Pappas (ORCID: https://orcid.org/0000-0002-0353-1785)
- Betty K. Hamilton (ORCID: https://orcid.org/0000-0003-1252-6539)
Institutions
- Cleveland Clinic (US)
- Walmart (United States) (US)
- Walsh University (US)
- Denver Health Medical Center (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Case Western Reserve University (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Infection Control and Hospital Epidemiology
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1017/ice.2025.10330
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00